Author:
Sadrkhanloo Mehrdokht,Paskeh Mahshid Deldar Abad,Hashemi Mehrdad,Raesi Rasoul,Motahhary Motahhar,Saghari Sam,Sharifi Laleh,Bokaie Saied,Mirzaei Sepideh,Entezari Maliheh,Aref Amir Reza,Salimimoghadam Shokooh,Rashidi Mohsen,Taheriazam Afshin,Hushmandi Kiavash
Subject
Pharmacology,General Medicine
Reference251 articles.
1. Prospect of prostate cancer treatment: armed CAR-T or combination therapy;Jiang;Cancers,2022
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung,2021
3. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer;Smith,2005
4. Zarrabi, A., et al., Role of ZEB family members in proliferation, metastasis, and chemoresistance of prostate cancer cells: Revealing signaling networks, 2021. 21(9): p. 749–767.
5. Sharifi, N., J.L. Gulley, and W.L.J.J. Dahut, Androgen deprivation therapy for prostate cancer, 2005. 294(2): p. 238–244.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献